• Acumen Health Holdings
  • Designs for Health
  • Everwell Health
  • Deerland Enzymes & Probiotics
  • Renaissance Acquisition Holdings
  • Revision Skincare / Goodier Cosmetics
  • Santa Cruz Nutritionals

Andrew B. Hochman

Senior Partner

Mr. Hochman is a Senior Partner of RoundTable. He joined the Firm in September 2007 as a Vice President, was promoted to Principal in conjunction with his role in Fund III, and then promoted to Partner in Fund IV. Mr. Hochman is principally focused on pharmaceutical investments and consumer healthcare where he is involved in all aspects of the transaction process, including deal sourcing, transaction structuring, valuation, due diligence, negotiations, financing, and execution. Mr. Hochman serves on the boards of directors of Santa Cruz Nutritionals, Revision Skincare/Goodier Cosmetics, and Deerland Probiotics & Enzymes, and previously served on the board of Aqua Pharmaceuticals prior to its sale.


  • Senior Partner, RoundTable, July 2019 – Present
  • Partner, RoundTable, September 2015– June 2019
  • Principal, RoundTable, July 2010 – September 2015
  • Vice President, RoundTable, September 2007 – July 2010
  • Vice President, Business Development, Graceway Pharmaceuticals, November 2005 – September 2007
  • Associate, GTCR Golder Rauner, July 2003 – November 2005
  • Analyst, William Blair & Company, July 2001 – July 2003


  • Bachelor’s degree in Economics from the Wharton School and Bachelor’s degree in Psychology from the University of Pennsylvania, Summa Cum Laude, 2001